New mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance

Details for Australian Patent Application No. 2003251731 (hide)

Owner Tibotec Pharmaceuticals Ltd.

Inventors Vingerhoets, Johan Hendrika Jozef; De Bethune, Marie-Pierre T.M.M.G; Azijn, Hilde

Agent Shelston IP

Pub. Number AU-B-2003251731

PCT Number PCT/EP03/50279

PCT Pub. Number WO2004/003227

Priority 60/393,025 01.07.02 US

Filing date 30 June 2003

Wipo publication date 19 January 2004

Acceptance publication date 18 September 2008

International Classifications

C12Q 1/48 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving transferase

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

C12Q 1/70 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

Event Publications

16 October 2003 Complete Application Filed

  Priority application(s): 60/393,025 01.07.02 US

4 March 2004 Application Open to Public Inspection

  Published as AU-B-2003251731

18 September 2008 Application Accepted

  Published as AU-B-2003251731

6 November 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 16 Oct 2008. Address for service in Australia - Shelston IP 60 Margaret Street Sydney NSW 2000

5 March 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 16 Oct 2008

5 March 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003251732-New mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance

2003251730-Bafilomycin-like metabolite from a novel Micromonospora species